Atrovent and Daklinza drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Atrovent (ipratropium bromide) and Daklinza (daclatasvir dihydrochloride). Common drug interactions include dizziness among females and embolism among males.

The phase IV clinical study analyzes what interactions people have when they take Atrovent and Daklinza. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Atrovent?

Atrovent has active ingredients of ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 33,210 Atrovent users. Check the latest studies of Atrovent.

What is Daklinza?

Daklinza has active ingredients of daclatasvir dihydrochloride. eHealthMe is studying from 3,312 Daklinza users. Check the latest studies of Daklinza.



On Apr, 07, 2026

27 people who take Atrovent and Daklinza together, and have interactions are studied.

Atrovent and Daklinza drug interactions.

What are the common drug interactions of Atrovent and Daklinza, by gender? *:

female:

  1. Dizziness
  2. Dyspnoea (difficult or laboured respiration)
  3. Extrasystoles

male:

  1. Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)
  2. Cough
  3. Influenza like illness
  4. Basophil count increased
  5. Blood alkaline phosphatase increased
  6. Blood bilirubin decreased
  7. Blood creatinine increased
  8. Bundle branch block (disruption in the normal flow of electrical pulses that drive the heart beat)
  9. C-reactive protein increased
  10. Cerebral calcification (abnormal deposits of calcium in certain areas of the brain)

What are the common drug interactions of Atrovent and Daklinza, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)
  2. Cough
  3. Diarrhoea
  4. Fatigue (feeling of tiredness)
  5. Hyperglycaemia (high blood sugar)
  6. Insomnia (sleeplessness)
  7. Oropharyngeal pain
  8. Thrombosis (formation of a blood clot inside a blood vessel)
  9. Influenza
  10. Genital herpes (herpes infection of genital)

60+:

  1. Basophil count increased
  2. Blood alkaline phosphatase increased
  3. Ejection fraction decreased (systolic heart failure)
  4. Eosinophil count decreased
  5. Gamma-glutamyltransferase increased
  6. General physical health deterioration (weak health status)
  7. Glomerular filtration rate decreased
  8. Haematocrit decreased
  9. Haemoglobin decreased
  10. Hypokinesia (decreased bodily movement)

What are the existing conditions these people have? *

  1. Hiv Infection: 25 people, 92.59%
  2. Hyperglycemia (high blood sugar): 16 people, 59.26%
  3. Cough: 14 people, 51.85%
  4. Heart Disease: 3 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Atrovent and Daklinza?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Atrovent and Daklinza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Atrovent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Daklinza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Atrovent and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Daklinza and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ipratropium bromide and daclatasvir dihydrochloride (the active ingredients of Atrovent and Daklinza, respectively), and Atrovent and Daklinza (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: